PeterUriFeigMD

PubMed

• 26 citations
  COVID-19 and the Renin-Angiotensin System.
  Line Malha, Franco B. Mueller, Mark S. Pecker, Samuel J. Mann, Phyllis August, Peter U. Feig> ;Kidney International Reports. 2020 Mar 27
• 39 citations
  Pulse Wave Velocities Derived From Cuff Ambulatory Pulse Wave Analysis.
  Joseph E. Schwartz, Peter U. Feig, Joseph L. Izzo> ;Hypertension. 2019 May 28
• 20 citations
  Sodium and Fluid Excretion With Torsemide in Healthy Subjects is Limited by the Short Duration of Diuretic Action
  Salim Shah, Bertram Pitt, D. Craig Brater, Peter U. Feig, Wen Shen, Fatima S. Khwaja, Christopher S. Wilcox> ;Journal of the American Heart Association. 2017 Oct 5
• 32 citations
  Clinical Use of Pulse Wave Analysis: Proceedings From a Symposium Sponsored by North American Artery
  Raymond R. Townsend, Henry R. Black, Julio A. Chirinos, Peter U. Feig, Keith C. Ferdinand, Michael J. Germain, Clive Rosendorff, Susan Steigerwalt, Jan Stepanek> ;Journal of Clinical Hypertension. 2015 Jul 1
• 125 citations
  Effects of an 11β-hydroxysteroid dehydrogenase type 1 inhibitor, MK-0916, in patients with type 2 diabetes mellitus and metabolic syndrome.
  Peter U. Feig, Suneri Shah, Anne Hermanowski-Vosatka, D. Plotkin, Martin S. Springer, S. Donahue, C. Thach, E. J. Klein, Eseng Lai, Keith D. Kaufman> ;Diabetes, Obesity & Metabolism. 2011 Jun 1
• 74 citations
  Efficacy and safety of the selective 11β-HSD-1 inhibitors MK-0736 and MK-0916 in overweight and obese patients with hypertension
  Sukrut Shah, Anne Hermanowski-Vosatka, Kendra Gibson, Rae Ann Ruck, Gang Jia, John Zhang, Peggy Hwang, Nicholas Ryan, Ronald B. Langdon, Peter U. Feig> ;Journal of the American Society of Hypertension. 2011 May 1
• 14 citations
  Training the Translational Scientist
  Rebecca D. Jackson, Sherine Gabriel, Anne Pariser, Peter Feig> ;Science Translational Medicine. 2010 Dec 22
• 7 citations
  Single-dose effects of isosorbide mononitrate alone or in combination with losartan on central blood pressure.
  Rhonda Kaufman, Irene Nunes, James A. Bolognese, Deborah L. Miller, Dennis Salotti, Jennifer M. McCarthy, William B. Smith, Gary A. Herman, Peter U. Feig> ;Journal of the American Society of Hypertension. 2010 Nov 1
• 7 citations
  Effects of the renin inhibitor MK-8141 (ACT-077825) in patients with hypertension.
  Charlotte Jones-Burton, Joseph Rubino, Sophie Roy, Yabing Mai, Alan G. Meehan, Bellet Marc, Peter U. Feig> ;Journal of the American Society of Hypertension. 2010 Sep 1
• 5 citations
  Central blood pressure measurements - An opportunity for efficacy and safety in drug development?
  Raymond R. Townsend, Mary J. Roman, Samer S. Najjar, John R. Cockcroft, Peter U. Feig, Norman Stockbridge> ;Journal of the American Society of Hypertension. 2010 Sep 1
• 10 citations
  Antihypertensive drug development: current challenges and future opportunities
  Peter U. Feig, Sophie Roy, Robert J. Cody> ;Journal of the American Society of Hypertension. 2010 Jul 1
• 371 citations
  Next-generation biomarkers for detecting kidney toxicity
  Joseph V. Bonventre, Vishal S. Vaidya, Robert Schmouder, Peter U. Feig, Frank Dieterle> ;Nature Biotechnology. 2010 May 1
• 40 citations
  Fifty Years of Thiazide Diuretic Therapy for Hypertension
  Marvin Moser, Peter U. Feig> ;Archives of Internal Medicine. 2009 Nov 9
• 12 citations
  A multicenter, randomized, double-blind, parallel-group trial of the antihypertensive efficacy and tolerability of a combination of once-daily losartan 100 mg/hydrochl...
  Gilbert W. Gleim, Joseph Rubino, Hongyan Zhang, Shahnaz Shahinfar, Beth Soffer, Paulette A. Lyle, Thomas W. Littlejohn, Peter U. Feig> ;Clinical Therapeutics. 2006 Oct 1
• 33 citations
  Chronic treatment of African-American type 2 diabetic patients with alpha-glucosidase inhibition.
  Peter Johnston, Peter U Feig, Robert F Coniff, Alice Krol, David E. Kelley, Arshag D. Mooradian> ;Diabetes Care. 1998 Mar 1
• 21 citations
  Long-Term Titrated-Dose α-Glucosidase Inhibition in Non-Insulin-Requiring Hispanic NIDDM Patients
  Peter Johnston, Peter U Feig, Robert F Coniff, Alice Krol, Jaime A. Davidson, Steven M. Haffner> ;Diabetes Care. 1998 Mar 1
• 7 citations
  The safety and efficacy of once-daily nifedipine coat-core in combination with atenolol in hypertensive patients. Adalat CC Cooperative Study Group.
  E. P. Mac Carthy, P. P. Pettis, L. Gibson, L. Schwartz, Peter U. Feig> ;Clinical Therapeutics. 1993 Nov 1
• 10 citations
  The efficacy and safety of once-daily nifedipine coat-core in the treatment of mild-to-moderate hypertension. Adalat CC Cooperative Study Group.
  Feig Pu, L. Gibson, Mac Carthy Ep, P. P. Pettis, L. Schwartz> ;Clinical Therapeutics. 1993 Nov 1
• 1 citations
  A comparison of once-daily atenolol and metoprolol using office and ambulatory blood pressure monitoring
  Gale H. Rutan, Peter U. Feig, Sherryl M. May, Audrey Kriegman, Ellen M. Brady> ;Journal of Clinical Pharmacology. 1993 May 1
• 11 citations
  Effectiveness of once-daily monotherapy with a new nifedipine sustained release calcium antagonist
  Albert A. Carr, Bottini Pb, Peter U. Feig, L. Michael Prisant, Seamus Mulligan, John Devane, Lloyd D. Fisher, R B Rhoades, E. Paul Mac Carthy> ;The American Journal of Cardiology. 1992 Apr 30
• 10 citations
  Increased platelet membrane sodium-proton exchange rate in spontaneously hypertensive rats.
  Peter U. Feig> ;American Journal of Hypertension. 1990 Dec 1
• 12 citations
  Angiotensin converting enzyme inhibitors: the end of end-stage renal disease?
  Peter U. Feig, Gale H. Rutan> ;Annals of Internal Medicine. 1989 Sep 15
• 41 citations
  Toxic interaction between acetazolamide and salicylate: case reports and a pharmacokinetic explanation.
  Kevin R. Sweeney, Dennis J. Chapron, J. Leonard Brandt, Irving H. Gomolin, Peter U Feig, Paul A. Kramer> ;Clinical Pharmacology and Therapeutics. 1986 Nov 1
• 19 citations
  Cellular mechanism of action of loop diuretics: Implications for drug effectiveness and adverse effects
  Peter U. Feig> ;The American Journal of Cardiology. 1986 Jan 24
• 13 citations
  Aminoglycoside nephrotoxicity: a double blind prospective randomized study of gentamicin and tobramycin
  Peter U. Feig, Peter P. Mitchell, Elias Abrutyn, Susan M. Brock, William R. Carney, Charles W. Graeber, Eva Horak, Robert W. Lyons, John F. Maher> ;The Journal of Antimicrobial Chemotherapy. 1982 Sep 1
• Join now to see all